Security key
09058V103
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX)
CUSIP: 09058V103
Q3 2020 13F Holders as of 30 Sep 2020
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 249,150,204
- Total 13F shares
- 127,504,811
- Share change
- -5,712,929
- Total reported value
- $438,191,012
- Put/Call ratio
- 123%
- Price per share
- $3.44
- Number of holders
- 150
- Value change
- -$23,494,376
- Number of buys
- 83
- Number of sells
- 77
Report period
Q3 2020
Institutions
150
Top holders
10
BCRX full security history
Newer quarter: Q4 2020
Previous quarter: Q2 2020
BIOCRYST PHARMACEUTICALS INC SEC filings
BIOCRYST PHARMACEUTICALS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09058V103
Recent filing periods:
Top shareholders of BCRX - BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| STATE STREET CORP |
13F
|
Company |
6.3%
|
15,578,395
|
$74,231,000 | — | 30 Jun 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
5.9%
|
14,666,914
|
$69,887,000 | — | 30 Jun 2020 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
5.5%
|
13,766,405
|
$65,597,000 | — | 30 Jun 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.4%
|
10,883,542
|
$51,859,000 | — | 30 Jun 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
3.4%
|
8,485,708
|
$40,434,000 | — | 30 Jun 2020 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
2.6%
|
6,565,541
|
$31,285,000 | — | 30 Jun 2020 | |
| Eversept Partners, LP |
13F
|
Company |
1.9%
|
4,847,792
|
$23,099,729 | — | 30 Jun 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
1.8%
|
4,456,519
|
$21,235,000 | — | 30 Jun 2020 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.1%
|
2,863,381
|
$13,644,000 | — | 30 Jun 2020 | |
| FMR LLC |
13F
|
Company |
1%
|
2,556,584
|
$12,182,000 | — | 30 Jun 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.89%
|
2,224,672
|
$10,600,000 | — | 30 Jun 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
2,210,664
|
$10,533,000 | — | 30 Jun 2020 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.85%
|
2,118,812
|
$10,096,000 | — | 30 Jun 2020 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.82%
|
2,042,099
|
$9,730,000 | — | 30 Jun 2020 | |
| ORACLE INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.8%
|
2,000,000
|
$9,530,000 | — | 30 Jun 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.77%
|
1,928,226
|
$9,187,000 | — | 30 Jun 2020 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.76%
|
1,900,000
|
$9,054,000 | — | 30 Jun 2020 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.76%
|
1,900,000
|
$9,054,000 | — | 30 Jun 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.72%
|
1,791,542
|
$8,537,000 | — | 30 Jun 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.68%
|
1,686,808
|
$8,037,000 | — | 30 Jun 2020 | |
| Woodline Partners LP |
13F
|
Company |
0.64%
|
1,590,841
|
$7,580,000 | — | 30 Jun 2020 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.59%
|
1,480,658
|
$7,048,000 | — | 30 Jun 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.57%
|
1,419,987
|
$6,766,000 | — | 30 Jun 2020 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.54%
|
1,357,848
|
$6,470,000 | — | 30 Jun 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.47%
|
1,161,155
|
$5,532,904 | — | 30 Jun 2020 | |
| DG Capital Management, LLC |
13F
|
Company |
0.46%
|
1,144,094
|
$5,452,000 | — | 30 Jun 2020 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.43%
|
1,075,000
|
$5,122,000 | — | 30 Jun 2020 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.38%
|
934,948
|
$4,455,000 | — | 30 Jun 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.37%
|
927,944
|
$4,422,000 | — | 30 Jun 2020 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.36%
|
900,608
|
$4,291,000 | — | 30 Jun 2020 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.36%
|
887,570
|
$4,229,000 | — | 30 Jun 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.33%
|
830,918
|
$3,959,000 | — | 30 Jun 2020 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.31%
|
767,087
|
$3,655,000 | — | 30 Jun 2020 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.3%
|
744,051
|
$3,545,000 | — | 30 Jun 2020 | |
| Formidable Asset Management, LLC |
13F
|
Company |
0.24%
|
600,000
|
$3,135,000 | — | 30 Jun 2020 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.23%
|
563,961
|
$2,687,000 | — | 30 Jun 2020 | |
| NORGES BANK |
13F
|
Company |
0.22%
|
543,493
|
$2,590,000 | — | 30 Jun 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.22%
|
542,129
|
$2,583,000 | — | 30 Jun 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.19%
|
480,122
|
$2,287,000 | — | 30 Jun 2020 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
0.19%
|
462,402
|
$2,203,000 | — | 30 Jun 2020 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.18%
|
436,500
|
$2,080,000 | — | 30 Jun 2020 | |
| David M. Knott |
13F
|
Individual |
0.16%
|
397,361
|
$1,893,000 | — | 30 Jun 2020 | |
| Swiss National Bank |
13F
|
Company |
0.15%
|
385,668
|
$1,838,000 | — | 30 Jun 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.15%
|
373,711
|
$1,779,000 | — | 30 Jun 2020 | |
| J. Goldman & Co LP |
13F
|
Company |
0.14%
|
359,944
|
$1,715,000 | — | 30 Jun 2020 | |
| Global IMC LLC |
13F
|
Company |
0.14%
|
348,249
|
$1,659,000 | — | 30 Jun 2020 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.14%
|
346,467
|
$1,651,000 | — | 30 Jun 2020 | |
| CITIGROUP INC |
13F
|
Company |
0.13%
|
311,702
|
$1,485,000 | — | 30 Jun 2020 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.12%
|
303,400
|
$1,446,000 | — | 30 Jun 2020 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.12%
|
289,964
|
$1,382,000 | — | 30 Jun 2020 |
Institutional Holders of BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) as of Q3 2020
As of 30 Sep 2020,
BIOCRYST PHARMACEUTICALS INC - COMMON STOCK (BCRX) was held by
150 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,504,811 shares.
The largest 10 holders included
STATE STREET CORP, BlackRock Inc., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, CITADEL ADVISORS LLC, Sarissa Capital Management LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), MILLENNIUM MANAGEMENT LLC, ORACLE INVESTMENT MANAGEMENT INC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
150
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2020 vs Q2 2020 Across Filers
Q2 2020 holders
160
Q3 2020 holders
150
Holder diff
-10
| Investor | Q2 2020 Shares | Q3 2020 Shares | Share Diff | Share Chg % | Q2 2020 Value $ | Q3 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.